Among the cells expressing foreign genes that are used for alzheimers therapy, HB1.F3.ChAT has proved its effectiveness. When these cells were applied to animals models with cognitive defects induced by AF64A and kainic acid, similarly safe and effective results were obtained. Taken together, it can be expected that therapies with cells that simultaneously express neurotransmitters and growth factors could achieve better results.